Maxim Group began coverage on shares of Sientra (NASDAQ:SIEN) in a research report released on Thursday morning, MarketBeat reports. The brokerage issued a buy rating and a $15.00 price target on the medical instruments supplier’s stock.
SIEN has been the subject of several other reports. BidaskClub cut Sientra from a hold rating to a sell rating in a report on Tuesday, January 9th. Zacks Investment Research cut Sientra from a buy rating to a hold rating in a report on Saturday, March 17th. William Blair reissued a buy rating on shares of Sientra in a report on Thursday, March 1st. ValuEngine cut Sientra from a hold rating to a sell rating in a report on Wednesday, March 7th. Finally, Canaccord Genuity reissued a buy rating and set a $19.00 price target on shares of Sientra in a report on Friday, January 5th. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company. The company presently has a consensus rating of Hold and an average target price of $13.50.
Shares of Sientra stock opened at $9.15 on Thursday. Sientra has a 52-week low of $7.20 and a 52-week high of $16.68.
A number of large investors have recently added to or reduced their stakes in SIEN. Senzar Asset Management LLC raised its holdings in Sientra by 271.6% in the 4th quarter. Senzar Asset Management LLC now owns 484,607 shares of the medical instruments supplier’s stock valued at $6,814,000 after acquiring an additional 354,200 shares in the last quarter. Pura Vida Investments LLC acquired a new position in Sientra in the 3rd quarter valued at $2,892,000. X Square Capital LLC acquired a new position in Sientra in the 4th quarter valued at $2,232,000. State Street Corp acquired a new position in Sientra in the 2nd quarter valued at $1,449,000. Finally, Northern Trust Corp raised its holdings in Sientra by 449.4% in the 2nd quarter. Northern Trust Corp now owns 149,227 shares of the medical instruments supplier’s stock valued at $1,451,000 after acquiring an additional 122,066 shares in the last quarter. 77.38% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: This story was published by Ticker Report and is the property of of Ticker Report. If you are accessing this story on another site, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/3298832/sientra-sien-research-coverage-started-at-maxim-group.html.
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.